These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28087869)

  • 1. Clinical Inquiry: Which patients with metabolic syndrome benefit from metformin?
    Stover L; Chi J; Kelsberg G; Safranek S
    J Fam Pract; 2016 Nov; 65(11):832-834. PubMed ID: 28087869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of medicinal chemistry in treating obesity, diabetes and metabolic syndrome.
    Ortúzar N
    ChemMedChem; 2013 Apr; 8(4):535-7. PubMed ID: 23529925
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
    Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
    Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of metabolic syndrome using fenofibrate, metformin or their combination.
    Nieuwdorp M; Stroes ES; Kastelein JJ;
    Diabetes Obes Metab; 2007 Nov; 9(6):869-78. PubMed ID: 17924869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a combination of rhGH and metformin on adiponectin levels in patients with metabolic syndrome.
    Herrmann BL; Saller B; Stratmann M; Berg C; Mann K; Janssen OE
    Horm Metab Res; 2005 Jan; 37(1):49-52. PubMed ID: 15702440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Inquiry: Does metformin prevent diabetes in at-risk adults?
    Mangahas T; Huang G; Neher J; Safranek S
    J Fam Pract; 2013 Aug; 62(8):436-7. PubMed ID: 24143338
    [No Abstract]   [Full Text] [Related]  

  • 7. Metformin use in polycystic ovary syndrome: metabolic benefits and diabetes prevention.
    Goodarzi MO; Azziz R
    Am J Med; 2008 Aug; 121(8):e9; author reply e11. PubMed ID: 18691471
    [No Abstract]   [Full Text] [Related]  

  • 8. Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.
    Rizzo M; Rizvi AA; Patti AM; Nikolic D; Giglio RV; Castellino G; Li Volti G; Caprio M; Montalto G; Provenzano V; Genovese S; Ceriello A
    Cardiovasc Diabetol; 2016 Dec; 15(1):162. PubMed ID: 27912784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome: are we at risk?
    Paudel B
    Nepal Med Coll J; 2007 Sep; 9(3):204-11. PubMed ID: 18092442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin improves skin capillary reactivity in normoglycaemic subjects with the metabolic syndrome.
    Kraemer de Aguiar LG; Laflor CM; Bahia L; Villela NR; Wiernsperger N; Bottino DA; Bouskela E
    Diabet Med; 2007 Mar; 24(3):272-9. PubMed ID: 17263761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of the therapy of patients with type II diabetes mellitus and metabolic syndrome].
    Bodnar PM; Kononenko LO
    Lik Sprava; 2000; (7-8):92-4. PubMed ID: 16786661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance.
    de Aguiar LG; Bahia LR; Villela N; Laflor C; Sicuro F; Wiernsperger N; Bottino D; Bouskela E
    Diabetes Care; 2006 May; 29(5):1083-9. PubMed ID: 16644641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current indications for metformin therapy.
    Tankova T
    Rom J Intern Med; 2003; 41(3):215-25. PubMed ID: 15526505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin for prevention of type 2 diabetes.
    Hess AM; Sullivan DL
    Ann Pharmacother; 2004; 38(7-8):1283-5. PubMed ID: 15150378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metformin can reduce the risk of colorectal cancer].
    Fransgård T; Gögenur I
    Ugeskr Laeger; 2015 May; 177(21):V12140659. PubMed ID: 26027593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect.
    Haddad M; Knani I; Bouzidi H; Berriche O; Hammami M; Kerkeni M
    Dis Markers; 2016; 2016():6248264. PubMed ID: 27829696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The renaissance of metformin in endocrine clinical practice.
    Milewicz A; Sieradzki J; Tendera-Małecka E; Skałba P; Jedrzejuk D
    Gynecol Endocrinol; 2009 May; 25(5):277-81. PubMed ID: 19903035
    [No Abstract]   [Full Text] [Related]  

  • 19. The 'worried-well', insulin resistance and metformin therapy.
    Distiller LA; Landau S; Joffe B; Kramer B; Blacking L
    S Afr Med J; 2005 Jun; 95(6):366. PubMed ID: 16100876
    [No Abstract]   [Full Text] [Related]  

  • 20. Case records of the Massachusetts General Hospital. Case 31-2006. A 15-year-old girl with severe obesity.
    Hoppin AG; Katz ES; Kaplan LM; Lauwers GY
    N Engl J Med; 2006 Oct; 355(15):1593-602. PubMed ID: 17035653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.